Azienda USL IRCCS Di Reggio Emilia — Clinical Trial Site

229 Registered trials

98 Currently recruiting

Organisation

Azienda USL IRCCS Di Reggio Emilia

Location

Reggio Emilia, Italy

Identifier

ORG-100007016

Address

Viale Umberto Primo 50, 42123, Italy

Departments

"Azienda USL-IRCCS di Reggio Emilia Struttura Complessa di Oncologia provinciale"
#1201: Nuclear Medicine
#2164: UOC Ematologia, Presidio Ospedaliero Arcispedale S. Maria Nuova
#380004: SOC di Neurologia
#40086: Reumatologia
#8001:Struttura Complessa di Oncologia Provinciale Arcispedale Santa Maria Nuova
#8505: Reumatologia
1000:S.C. Medicina Nucleare
1302 S.C. Oncologia Medica
1402: S.C. Medicina Nucleare
2051:U. O. Reumatologia
2103: S.C. Reumatologia
2103: U.O Reumatologia
3108: Ematologia
3308:U.O.C. Cardiologia Ospedaliera
380012: Ematologia
38006: S.C. Medicina Nucleare Dip Oncologico e Tecnologie Avanzate
4000:U.O. Reumatologia
4109:Reumatologia
4202: Oncology and High Technology Department, Nuclear Medicine Unit
6002:S.C. Ematologia
93133019: S.O.C. Oncologia Medica Provinciale
Arcispedale Santa Maria Nuova - Dipartimento di Medicine Specialistiche - SC Pneumologia
Arcispedale Santa Maria Nuova - Ematologia
Arcispedale Santa Maria Nuova, Ematologia,Viale Risorgimento 80 Reggio Emilia,42123,Italy
AUSL - ASMN Reggio Emilia - U.O. Dermatology
Azienda USL IRCCS Di Reggio Emilia
Cardiology
Clinical hematology
D.H. Oncologico
Department Internal Medicine and Medical Specialties Complex Structure of Rheumatology
Dipartimento di Ematologia
Dipartimento di Medicina Interna e Specialità Mediche
Dipartimento di Medicina Specialistica
DIPARTIMENTO DI ONCOLOGIA E TECNOLOGIE AVANZATE
Dipartimento Internistico
DIPARTIMENTO ONCOLOGICO E TECNOLOGIE AVANZATE
DIPARTIMENTO ONCOLOGICO E TECNOLOGIE AVANZATE - CORE
DIPARTIMENTO ONCOLOGICO E TECNOLOGIE AVANZATE - UO EMATOLOGIA DAY SERVICE
DIPARTIMENTO ONCOLOGICO E TECNOLOGIE AVANZATE-UO EMATOLOGIA DAY SERVICE
Ematologia
Ematologia - Azienda Unità Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova
General Surgery
Hematology
Hematology Unit
Immunologia Oculare
Internal Medicine
IT30020:UOC Ematologia
Medical Oncology
Medical Oncology Unit
Medical Ongolory at Ongolofica Medica Provinciale
Medicine specialistiche
N/A
Nefrologia e Dialisi
Ocular Immunology
Ocular Immunology Unit
Onclologia Medica
Oncologia
Oncologia medica
Oncologia Medica / SS Coordinamento Breast Unit
Oncologia Medica Provanciale
Oncologia Medica Provinciale
Oncologia Medica Provinciale - Presidio Arcispedale S. Maria Nuova Reggio Emila
Oncologia Medica Provinciale -Ospedale Civile di Guastalla
Oncologia Medica, A.U.S.L. di Reggio Emilia - IRCCS - Presidio Arcispedale S. Maria Nuova
ONCOLOGICO E TECNOLOGIE AVANZATE
Oncology
Oncology and Advanced Technologies
Oncology and Advanced Technologies, SC Hematology
Oncology Service
Ostetricia e Ginecologia
Ostetricia-Ginecologia
Pneumologia
Pneumology
Provincial Medical Oncology
Provincial Oncology
Radiotherapy
Reumatologia
Rheumatologie und Immunologie
Rheumatology
Rheumatology Unit
S.C. di Oncologia Medica Provinciale
S.C. di Reumatologia
S.C. Ematologia
S.C. Ematologia, Dip.to Oncologico e Tecnologie Avanzate
S.C. Medicina Cardiovascolare
S.C. Nefrologia e Dialisi
S.C. Oncologia
S.C. Oncologia - CORE
S.C. Oncologia Medica
S.C. Oncologia Medica Provinciale
S.C. Oncologia Provinciale
S.O.C Oncologia provinciale
S.O.C. Medicina Cardiovascolare
S.O.C. Oncologia Provinciale
SC Ematologia
SC Ematologia-Arcispedale S. Maria Nuova Reggio Emilia
SC EMATOLOGIA, 2^ piano PADIGLIONE CORE, viale Risorgimento,80
SC Ematologia, Dipartimento Oncologico e Tecnologie Avanzate
SC Medicina Nucleare
SC Nefrologia e Dialisi
SC Oncologia
SC Oncologia Provinciale
SC Pneumologia
SC Radioterapia
SC Radioterapia Oncologica
SC Reumatologia
SOC CARDIOLOGIA OSPEDALIERA
SOC di Oncologia Provinciale - PO Santa Maria Nuova e PO di Guastalla
SOC di Oncologia provinciale di Reggio Emilia
SOC of Neurology, Neuromotor Department
SOC Oncologia Provinciale
Specialistic Medicine
SSD Skin Cancer Center
Struttura Complessa Oncologia Medica Provinciale
U.O. Oncologia Medica
U.O.C. Cardiologia
Unità Clinica di Fase 1 - Oncologia Medica Provinciale
Unità di Ematologia
Unità Operativa di Oncologia Medica
Unità Riabilitazione Disabilità Gravi Età Evolutiva
Unità trial clinici di reumatologia
UO di oncologia medica
UO Ematologia
UO Reumatologia
UOC di Ematologia
UOC Ematologia
UOC Oncologia Medica
UOC Oncologia Provinciale

Clinical trials at this site (229)

Search interface

Phase III trial comparing local radiotherapy alone or with Obinutuzumab in early stage Follicular Lymphoma: the GAZEBO Trial. Recruiting

2022-502775-29-01 Early stage Follicular Lymphoma 5 2023-12-14
177Lu-edotreotide compared to everolimus in neuroendocrine tumors of the lung and thymus Recruiting

2022-502154-13-00 Patients with well to moderately differentiated neuroen 5 2023-10-27
Neo-adjuvant Chemo and immunotherapy with durvalumab (MEDI4736) and tremelimumab (MEDI1123) In The pre-operAtive Treatment of locally advanc… Recruiting

2024-518656-23-00 locally advanced cholangiocarcinoma 4 2023-09-01
First-line combination of Bcl-2 inhibitor and monoclonal antibody followed by administration of Bcl-2 inhibitor alone or combination of Bcl-… Recruiting

2023-510431-11-00 Chronic Lymphocytic Leukemia 4 2023-07-21
Phase 2 trial of Translational approach to first line cHemoimmunotherapy followed by maintenance with pembrOlizumab and olaparib in Extensiv… Recruiting

2024-514666-39-00 Extensive-Stage Small-Cell Lung Cancer (ES SCLC) 4 2023-03-16
"APalutamide and stEReotactic body radiation therapy for low burden metastatic hormone senSItive prostate cancer, a rANdomized trial -PERSIA… Recruiting

2022-501894-37-00 prostate cancer 4 2023-03-02
phase I/II b study of atezolizumab and BEGEV as first salvage treatment in patients with relapsed or refractory Hodgkin’s lymphoma candidate… Recruiting

2024-511631-10-00 Hodgkin’s lymphoma 9 2023-02-27
WOEST-3 Recruiting

2022-502140-13-00 Atrial fibrillation Acute coronary syndrome Chronic cor 6 2023-01-11
A study of tucatinib with trastuzumab and mFOLFOX6 versus standard of care treatment in first-line HER2+ metastatic colorectal cancer Recruiting

2024-514180-25-00 unresectable or metastatic HER2+ colorectal cancer 5 2022-11-21
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Dia… Recruiting

2023-510384-36-00 Newly Diagnosed Multiple Myeloma 5 2022-09-13
A Phase 3 Study Comparing Pirtobrutinib to Ibrutinib in CLL/SLL Recruiting

2023-507699-38-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5 2022-08-30
An Open Label, Phase 2 Study to Evaluate Activity and Safety of Daratumumab in combination with Bortezomib and Dexamethasone in patients wit… Recruiting

2024-511635-94-00 Relapsed or Refractory Plasmablastic lymphoma 4 2022-07-11
Temozolomide and irinotecan consolidation in patients with MGMT silenced, microsatellite stable colorectal cancer with persistence of minima… Recruiting

2024-515681-14-00 Stage II (pT4)/III colorectal cancer with positive circ 4 2022-05-02
A study of MK-7240/PRA023 in patients with Systemic Sclerosis Associated with Interstitial Lung Disease Recruiting

2023-509743-27-00 Systemic sclerosis associated with interstitial lung di 4 2022-04-29
A Phase 2 Study to Evaluate the Efficacy and Safety of MK-1026 in Participants with Hematologic Malignancies Recruiting

2023-504931-42-00 Chronic lymphocytic leukemia/Small lymphocytic lymphoma 4 2021-04-06
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the i… Recruiting

2023-504417-67-00 Psoriatic Arthritis, Ankylosing Spondylitis, Non-radiog 6 2020-12-22
The study is aimed at evaluating the feasibility of a hypomethylating treatment combined with hematopoietic stem cell transplantation in com… Recruiting

2023-510515-19-00 Higher-risk-myelodysplastic syndromes 5 2020-11-27
NeoAspMet - Neoadjuvant Aspirin and/or Metformin during preoperative induction chemotherapy and chemoradiotherapy for locally-advanced recta… Recruiting

2024-519007-10-00 Locally advanced stage II/III rectal cancer 10 2020-10-22
RAndomized, open label, multicenter study of Docetaxel versus an Androgen Receptor-targeted agent (abiraterone orenzalutamide) as first-line… Recruiting

2024-518623-30-00 metastatic castration resistant prostate cancer without 6 2020-10-01
Study to determine the efficacy of Gemtuzumab Ozogamicin, together with standard chemotherapy, on minimal residual disease levels, in adult … Recruiting

2023-510433-29-00 Favorable-intermediate-risk Acute Myeloid Leukemia 5 2020-09-24
Study to identify the most appropriate therapy for patients with Acute Myeloid Leukemia carrying FLT3 mutation, using the PBC biomarker to c… Recruiting

2023-505901-17-00 Acute Myeloid Leukemia (LMA) with FLT3 mutation 5 2020-04-24
Phase II randomized trial comparing atezolizumab versus atezolizumab plus bevacizumab as first-line treatment in PD-L1 high advanced non-sm… Recruiting

2024-517200-10-00 Advanced non-small-cell lung cancer 4 2020-01-31
A phase II study of Pembrolizumab plus Carboplatin in BRCA-related metastatic breast cancer Recruiting

2024-515686-34-00 BRCA-related metastatic breast cancer 4 2018-11-16
A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer Ended

2024-519773-19-00 Gastroesophageal Junction Adenocarcinoma 5 2025-07-31